XML 131 R117.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT INFORMATION Segment Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Oct. 31, 2019
Segment Reporting Information [Line Items]      
Segment Reporting Reconciliation Item Assets $ 7,900 $ 7,033  
Cash and cash equivalents 1,484 1,441 $ 1,382
Short-term Investments 91 0  
Prepaid expenses 91 106  
Long-term investments 185 158  
Long term and other receivables 126 114  
Deferred tax assets 280 424  
Right-of-use asset 178 175  
Other 341 220  
Total assets 10,705 9,627  
Capital expenditures 188 119 $ 155
Other Noncurrent Assets [Member]      
Segment Reporting Information [Line Items]      
Deferred tax assets 309 380  
Life Sciences and Applied Markets      
Segment Reporting Information [Line Items]      
Total assets 3,078 3,143  
Capital expenditures 45 44  
Diagnostics and Genomics      
Segment Reporting Information [Line Items]      
Total assets 3,320 2,515  
Capital expenditures 100 34  
Agilent CrossLab      
Segment Reporting Information [Line Items]      
Total assets 1,502 1,375  
Capital expenditures 43 41  
Segment Total      
Segment Reporting Information [Line Items]      
Total assets 7,900 7,033  
Capital expenditures $ 188 $ 119